D. Keefe

A. Stringer, J. Bowen, R. Logan, 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Overdiagnosis of screen‐detected breast cancer

D. Currow, K. Canfell, D. Roder, 2021, The Medical journal of Australia.

Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy.

D. Rosenthal, S. Sonis, S. Gordon, 2019, Journal of the National Cancer Institute. Monographs.

Intestinal mucositis: mechanisms and management

D. Keefe, 2007, Current opinion in oncology.

Cancer Australia consensus statement on COVID‐19 and cancer care: embedding high value changes in practice

D. Hector, D. Keefe, C. Anderiesz, 2021, The Medical journal of Australia.

The Prevalence and Investigation of Risk Factors of Oral Mucositis in a Pediatric Oncology Inpatient Population; a Prospective Study

R. Logan, D. Keefe, S. Gue, 2017, Journal of pediatric hematology/oncology.

COVID-19 recovery: implications for cancer care clinicians

D. Keefe, Z. Wong, V. Milch, 2021, Supportive Care in Cancer.

Emerging drugs for chemotherapy-induced mucositis

S. Sonis, J. Bowen, D. Keefe, 2008 .

Dual contribution of the gut microbiome to immunotherapy efficacy and toxicity: supportive care implications and recommendations

N. Hart, S. Costello, A. Chan, 2022, Supportive Care in Cancer.

Mucositis

R. Logan, R. Gibson, D. Keefe, 2018, Textbook of Palliative Care.

Mucositis in the treatment of haematological malignancies.

M. Giovannini, A. Siniscalchi, D. Keefe, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats

A. Stringer, J. Bowen, R. Logan, 2007, Cancer biology & therapy.

VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight loss

A. Stringer, J. Bowen, R. Gibson, 2007, Cancer biology & therapy.

Rapid Protocol Development, Study Startup and Enrolment of a Prospective Study of COVID-19 Vaccination for Patients with Cancer: A Collaborative Approach

D. Keefe, E. Segelov, E. Ahern, 2022, Vaccines.

Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines.

S. Elad, P. Bossi, R. Lalla, 2019, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls

D. Peterson, M. Schubert, D. Keefe, 2006, Supportive Care in Cancer.

Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy

A. Barsevick, L. Elting, B. Koczwara, 2014, Cancer Chemotherapy and Pharmacology.

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

D. McGuire, L. Elting, S. Sonis, 2014, Cancer.

Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs.

S. Sonis, A. Stringer, J. Bowen, 2008, Cancer Biology & Therapy.

Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis

S. Sonis, A. Stringer, J. Bowen, 2008, Cancer Chemotherapy and Pharmacology.

Matrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity?

R. Logan, R. Gibson, D. Keefe, 2013, Oral diseases.

What sort of follow-up services would Australian breast cancer survivors prefer if we could no longer offer long-term specialist-based care? A discrete choice experiment

J. Ratcliffe, J. Eliott, J. Karnon, 2014, British Journal of Cancer.

Perspectives on cancer therapy‐induced mucosal injury

L. Elting, E. Rubenstein, B. Bekele, 2004, Cancer.

Clinical Practice Guidelines for the Prevention and Treatment of Mucositis

D. McGuire, L. Elting, S. Sonis, 2007 .

Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

D. McGuire, L. Elting, E. Rubenstein, 2004, Cancer.

Gastrointestinal mucositis: a new biological model

D. Keefe, 2004, Supportive Care in Cancer.

Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study

S. Sonis, D. Peterson, R. Lalla, 2009, Supportive Care in Cancer.

Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study

J. Finnie, N. Al-Dasooqi, J. Bowen, 2017, Supportive Care in Cancer.

Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?

N. Al-Dasooqi, J. Bowen, R. Gibson, 2009, Cancer Chemotherapy and Pharmacology.

Supportive care silos: time to forge cross-links, using mucositis as an example.

D. Keefe, 2007, Current opinion in supportive and palliative care.

Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy

A. Garden, R. Tishler, L. Elting, 2008, Cancer.

Influence of periodontitis on the experience of oral mucositis in cancer patients undergoing head and neck radiotherapy: a pilot study

P. Bartold, R. Logan, D. Keefe, 2014, Supportive Care in Cancer.

Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses

Jared M. Campbell, M. Peters, M. Stephenson, 2016, Cancer Chemotherapy and Pharmacology.

HER2 Targeted Therapy‐Induced Gastrointestinal Toxicity: From the Clinical Experience to Possible Molecular Mechanisms

N. Al-Dasooqi, J. Bowen, R. Gibson, 2012 .

Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades—trends by age and in the elderly

G. Farshid, D. Roder, J. Kollias, 2017, Journal of evaluation in clinical practice.

Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice

B. Han, Shiying Yu, A. Chan, 2014, Supportive Care in Cancer.

Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats

A. Stringer, J. Bowen, R. Logan, 2008, Cancer biology & therapy.

Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage

A. Cummins, J. Bowen, R. Gibson, 2006, Supportive Care in Cancer.

Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus

K. Chiam, D. Watson, D. Hussey, 2020, World journal of gastroenterology.

Pathobiology of Cancer Regimen-Related Toxicities

S. Sonis, D. Keefe, 2013, Springer New York.

The changing paradigm for supportive care in cancer patients

J. Lees, A. Chan, D. Keefe, 2014, Supportive Care in Cancer.

Supportive care in cancer—a MASCC perspective

F. Roila, C. Ripamonti, I. Olver, 2020, Supportive Care in Cancer.

Role of p53 in irinotecan-induced intestinal cell death and mucosal damage

A. Prabowo, A. Cummins, A. Stringer, 2007, Anti-cancer drugs.

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma

George C. Mayne, David I. Watson, Damian J. Hussey, 2015, Journal of Gastrointestinal Surgery.

Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice—a longitudinal analysis

W. Su, Shiying Yu, A. Chan, 2014, Supportive Care in Cancer.

Dacomitinib‐induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats

J. Finnie, J. Bowen, R. Gibson, 2017, International journal of cancer.

Rationale and design of the Pan Australasian chemotherapy-induced emesis burden of illness study

Shiying Yu, A. Chan, D. Keefe, 2014, Supportive Care in Cancer.

Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis

A. Stringer, J. Bowen, R. Logan, 2010, Radiation oncology.

Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.

Rachel J Gibson, Joanne M Bowen, A. Stringer, 2009, Current drug metabolism.

European Society for Medical Oncology (ESMO) position paper on supportive and palliative care

E. Bruera, S. Kaasa, M. Aapro, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy—a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines

Shiying Yu, Jin-Tung Liang, A. Chan, 2014, Supportive Care in Cancer.

Predictors of acute adverse events from rapid rituximab infusion

T. Schultz, D. Lang, Alan Pearson, 2013, Supportive Care in Cancer.

Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat

A. Stringer, N. Al-Dasooqi, J. Bowen, 2010, Experimental biology and medicine.

A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-κB, COX-1, and COX-2

A. Stringer, J. Bowen, R. Gibson, 2007, Molecular Cancer Therapeutics.

Fluoropyrimidine and platinum toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.

Jared M. Campbell, M. Peters, M. Stephenson, 2016, Pharmacogenomics.

Dacomitinib‐induced diarrhea: Targeting chloride secretion with crofelemer

J. Bowen, R. Gibson, D. Keefe, 2018, International journal of cancer.

Chemotherapy-Induced Diarrhea Is Associated with Changes in the Luminal Environment in the DA Rat

A. Stringer, J. Bowen, R. Logan, 2007, Experimental biology and medicine.

Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients

J. Lees, N. Al-Dasooqi, J. Bowen, 2009, Investigational New Drugs.

Nuclear factor κB (NFκB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes

J. Bowen, R. Gibson, A. Yeoh, 2005 .

Selection of Housekeeping Genes for Gene Expression Studies in a Rat Model of Irinotecan-Induced Mucositis

A. Stringer, N. Al-Dasooqi, J. Bowen, 2011, Chemotherapy.

the dark agouti rat Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in

A. Stringer, N. Al-Dasooqi, J. Bowen, 2010 .

Radiation therapy-induced mucositis: relationships between fractionated radiation, NF-kappaB, COX-1, and COX-2.

A. Stringer, J. Bowen, R. Logan, 2006, Cancer treatment reviews.

Cytotoxic chemotherapy upregulates pro‐apoptotic Bax and Bak in the small intestine of rats and humans

A. Cummins, J. Bowen, R. Gibson, 2005, Pathology.

Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes.

J. Bowen, R. Gibson, A. Yeoh, 2005, International journal of radiation oncology, biology, physics.

Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer

M. R. Inglis, A. Cummins, Rachel J Gibson, 2003, Journal of gastroenterology and hepatology.

Mobile Health Divide Between Clinicians and Patients in Cancer Care: Results From a Cross-Sectional International Survey

K. Desouza, M. Cucciniello, F. Petracca, 2019, JMIR mHealth and uHealth.

Mucositis management in patients with cancer.

D. Keefe, 2006, Supportive cancer therapy.

Disparities in cancer stage at diagnosis and survival of Aboriginal and non-Aboriginal South Australians.

G. Farshid, D. Roder, M. Eckert, 2017, Cancer epidemiology.

Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy

M. Ramoni, S. Sonis, G. Aprile, 2008, Cancer.

Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice

D. Peterson, M. Schubert, D. Keefe, 2006, Supportive Care in Cancer.

Assessing impact of organised breast screening across small residential areas—development and internal validation of a prediction model

G. Farshid, D. Roder, T. Niyonsenga, 2017, European journal of cancer care.

How was the intern year?: self and clinical assessment of four cohorts, from two medical curricula

Gillian A Laven, A. Tonkin, D. Keefe, 2014, BMC medical education.

Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum

D. Roder, M. Oehler, D. Keefe, 2019, BMJ Open.

HER2 targeted therapies for cancer and the gastrointestinal tract.

N. Al-Dasooqi, J. Bowen, R. Gibson, 2009, Current drug targets.

Systematic review of agents for the management of gastrointestinal mucositis in cancer patients

S. Elad, R. Lalla, N. Blijlevens, 2012, Supportive Care in Cancer.

Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival

D. Roder, C. Karapetis, T. Price, 2019, BMJ Open.

Tumor control versus adverse events with targeted anticancer therapies

Dorothy M. K. Keefe, Emma H. Bateman, D. Keefe, 2012, Nature Reviews Clinical Oncology.

Challenges in supportive cancer care: perspectives from the Asia Pacific and Middle East

M. Aapro, D. Kwong, R. Kanesvaran, 2016, Supportive Care in Cancer.

Establishment of a Single-Dose Irinotecan Model of Gastrointestinal Mucositis

J. Finnie, J. Bowen, R. Gibson, 2007, Chemotherapy.

DOES ONE SIZE FIT ALL? COST UTILITY ANALYSES OF ALTERNATIVE MAMMOGRAPHIC FOLLOW-UP SCHEDULES, BY RISK OF RECURRENCE

J. Karnon, T. Bessen, D. Keefe, 2015, International Journal of Technology Assessment in Health Care.

Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience

J. Lees, D. Keefe, N. Horvath, 2006, Supportive Care in Cancer.

GERIATRIC ONCOLOGY: A MEDICAL SUB-SPECIALTY WHOSE TIME HAS COME

D. Keefe, R. Prowse, 2009 .

Erratum: MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy (Cancer (2014) 120 (1453-1661))

D. McGuire, L. Elting, S. Sonis, 2015 .

A Prospective Audit of Inpatient Medical Oncology Consultation Patterns in a Tertiary Teaching Hospital in South Australia

D. Keefe, C. Hocking, S. O’neill, 2014 .

Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy

C. Karapetis, J. Tuke, J. Bowen, 2023, Cancer Chemotherapy and Pharmacology.

The combination of oral and small intestinal mucositis, pediatrics and biomarkers: A particularly tricky problem!

R. Gibson, D. Keefe, 2006, Cancer biology & therapy.

Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?

S. Sonis, A. Stringer, J. Bowen, 2008, Cancer Chemotherapy and Pharmacology.

Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival

D. Roder, M. Oehler, I. Olver, 2018, BMC Cancer.

Colorectal cancer treatment and survival: the experience of major public hospitals in south Australia over three decades.

D. Roder, M. Eckert, C. Karapetis, 2015, Asian Pacific journal of cancer prevention : APJCP.

Breast cancer screening—opportunistic use of registry and linked screening data for local evaluation

G. Farshid, D. Roder, J. Kollias, 2017, Journal of evaluation in clinical practice.

Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy

S. Sonis, R. Logan, R. Gibson, 2007 .

New frontiers in mucositis.

S. Sonis, D. Peterson, D. Keefe, 2012, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicity

A. Stringer, N. Al-Dasooqi, J. Bowen, 2017, Supportive Care in Cancer.

Tyrosine kinase inhibitors and gut toxicity: a new era in supportive care

L. Anthony, D. Keefe, 2008, Current Opinion in Supportive and Palliative Care.

Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia

D. Roder, C. Karapetis, T. Price, 2019, BMC Cancer.

Technological advances in mucositis research: new insights and new issues.

J. Bowen, R. Gibson, D. Keefe, 2008, Cancer treatment reviews.

D. Keefe, Stephen T. S Onis, 2007 .

Colorectal cancer treatment and survival: the experience of major public hospitals in south Australia over three decades.

D. Roder, C. Karapetis, T. Price, 2015, Asian Pacific journal of cancer prevention : APJCP.

Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival

D. Roder, M. Oehler, I. Olver, 2018, BMC Cancer.

The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia

D. Roder, M. Eckert, M. Oehler, 2018, European Journal of Cancer Care.

Mucositis guidelines: what have they achieved, and where to from here?

D. Keefe, 2006, Supportive Care in Cancer.

Emerging drugs for chemotherapy-induced mucositis.

S. Sonis, J. Bowen, D. Keefe, 2008, Expert Opinion on Emerging Drugs.

Use of Project Teams in Preclinical Development

J. Bowen, R. Gibson, D. Keefe, 2010 .

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

D. McGuire, L. Elting, S. Sonis, 2014, Cancer.

The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes.

M. Giovannini, F. Efficace, D. Keefe, 2012, Cardiovascular & hematological agents in medicinal chemistry.

DOES ONE SIZE FIT ALL? COST UTILITY ANALYSES OF ALTERNATIVE MAMMOGRAPHIC FOLLOW-UP SCHEDULES, BY RISK OF RECURRENCE

J. Karnon, D. Keefe, Taryn Bessen, 2015, International Journal of Technology Assessment in Health Care.

Mucositis

R. Logan, R. Gibson, D. Keefe, 2018, Textbook of Palliative Care.

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma

D. Watson, D. Hussey, S. Thompson, 2015, Journal of Gastrointestinal Surgery.

Microbiota and their role in the pathogenesis of oral mucositis.

T. Wiele, A. Stringer, D. Keefe, 2015, Oral diseases.

Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

M. Schubert, D. Keefe, C. Cooksley, 2004, Cancer.